Craig Bijou

Stock Analyst at B of A Securities

(3.82)
# 540
Out of 4,818 analysts
61
Total ratings
61.76%
Success rate
59.85%
Average return

Stocks Rated by Craig Bijou

RxSight
Mar 21, 2025
Maintains: Buy
Price Target: $60$36
Current: $14.48
Upside: +148.62%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235$140
Current: $133.00
Upside: +5.26%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18$17
Current: $12.78
Upside: +33.07%
Globus Medical
Jan 9, 2025
Upgrades: Neutral
Price Target: $80$97
Current: $71.90
Upside: +34.91%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26$18
Current: $16.32
Upside: +10.33%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135$145
Current: $120.49
Upside: +20.34%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92$103
Current: $93.79
Upside: +9.82%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $60.34
Upside: +40.87%
PROCEPT BioRobotics
Aug 22, 2024
Maintains: Buy
Price Target: $80$94
Current: $55.70
Upside: +68.76%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94$86
Current: $64.89
Upside: +32.53%
Initiates: Buy
Price Target: $95
Current: $80.94
Upside: +17.37%
Maintains: Buy
Price Target: $43$36
Current: $13.89
Upside: +159.18%
Reiterates: Overweight
Price Target: $23$45
Current: $7.47
Upside: +502.41%
Maintains: Overweight
Price Target: $1$8
Current: $0.40
Upside: +1,886.59%
Maintains: Neutral
Price Target: $60$30
Current: $6.58
Upside: +355.93%
Reiterates: Overweight
Price Target: $17$13
Current: $8.82
Upside: +47.39%
Maintains: Neutral
Price Target: $48$42
Current: $13.48
Upside: +211.57%
Reiterates: Overweight
Price Target: $207$230
Current: $487.93
Upside: -52.86%
Maintains: Neutral
Price Target: $190$230
Current: $357.11
Upside: -35.59%